Hematopoietic stem cell transplantation across major genetic barriers: Tolerance induction by megadose CD34 cells and other veto cells

Annals of the New York Academy of Sciences

Volumn 996, Issue , 2003, Pages 72-79

  Reisner, Yair ^a   Gur, Hilit ^a   Reich Zeliger, Shlomit ^a   Martelli, Massimo F ^b   Bachar Lustig, Esther ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Bone marrow; Non myeloablative conditioning; Tolerance

Indexed keywords

CASPASE INHIBITOR; CD34 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2;

APOPTOSIS; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL ACTIVITY; CELL CONTACT; CELL COUNT; CELL GROWTH; CELL POPULATION; CELL SURVIVAL; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DONOR; EFFECTOR CELL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST; HUMAN; IMMUNOLOGICAL TOLERANCE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PROTEIN PURIFICATION; STEM CELL; T LYMPHOCYTE;

EID: 0037792038     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03235.x     Document Type: Conference Paper

References (23)

1. ANASETTI, C., P.G. BEATTY, R. STORB, et al. 1990. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum. Immunol. 29: 79-91.
2. REISNER, Y., N. KAPOOR, D. KIRKPATRICK, et al. 1983. Transplantation for severe combined immunodeficiency with HLA-A,B.D.DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61: 341.
3. KERNAN, N.A., N. FLOMENBERG, B. DUPONT & R.J. O'REILLY. 1987. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 43: 842-847.
4. LAPIDOT, T., A. TERENZI, T.S. SINGER, et al. 1989. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood 73: 2025-2032.
5. BACHAR-LUSTIG, E., N. RACHAMIM, H.W. LI, et al. 1995. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nature Med. 1: 1268-1273.
6. BENSINGER, W., J. SINGER, F. APPELBAUM, et al. 1993. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81: 3158-3165.
7. SHERIDAN, W.P., C. GLENN-BEGLEY, C.A. JUTTNER, et al. 1992. Effect of peripheral-blood progenitor cells mobilised by filgrastin (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339: 640-644.
8. AVERSA, F., A. TABILIO, A. TERENZI, et al. 1994. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84: 3948-3955.
9. REISNER, Y. & M.F. MARTELLI. 1995. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol. Today 16: 437-440.
10. AVERSA, F., A. TABILIO, A. VELARDI, et al. 1998. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N. Engl. J. Med. 339: 1186-1193.
11. MARTELLI, M.F., F. AVERSA, E. BACHAR-LUSTIG, et al. 2002. Transplants across human leukocyte antigen barriers. Semin. Hematol. 39: 48-56.
12. RACHAMIM, N., J. GAN, H. SEGALL, et al. 1998. Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 65: 1386-1393.
13. + cells. Blood 99: 4174-4181.
14. MATHEW, J.M., L. FULLER, M. CARRENO, et al. 2000. Involvement of multiple subpopulations of human bone marrow cells in the tegulation of allogeneic cellular immune responses. Transplantation 70: 1752-1760.
15. 1 T cells. Blood 94: 3212-3221.
16. SATO, N., K. SAWADA, K. KOIZUMI, et al. 1993. In vitro expansion of human peripheral blood CD34+ cells. Blood 82:3600-3609.
17. WARREN, M.K., W.L. ROSE, L.D. BEALL & J. CONE. 1995. CD34+ cell expansion and expression of lineage markers during liquid culture of human progenitor cells. Stem Cells 13: 167-174.
18. KATAYAMA, Y., K. TAKENAKA, N. MAHMUT, et al. 1998. Replating potential of colony-forming units of granulocytes/macrophages (CFU-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL- 6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin. Int. J. Hematol. 68: 157-168.
19. HUMEAU, L., R. NAMIKAWA, F. BARDIN, et al. 1999. Ex vivo manipulations alter the reconstitution potential of mobilized human CD34+ peripheral blood progenitors. Leukemia 13: 438-452.
20. LIU, J., K. LI, P.M. YUEN, et al. 1999. Ex vivo expansion of enriched CD34+ cells from neonatal blood in the presence of thrombopoietin, a comparison with cord blood and bone marrow. Bone Marrow Transplant 24: 247-252.
21. QIU, L., R. MEAGHER, S. WELHAUSEN, et al. 1999. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. J. Hematother. Stem Cell Res. 8: 609-618.
22. REICH-ZELIGER, S., Y. ZHAO, R. KRAUTHGAMER, et al. Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. Immunity 13: 507-515.
23. BACHAR-LUSTIG, E., S. REICH-ZELIGER, et al. 2002. Synergism between rapamycin and host-non-reactive veto CTLs in murine models for BM allograft rejection: a new approach to facilitate engraftment of T cell depleted allogeneic BMT under reduced intensity conditioning. Blood 100: 211a.